Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Services
Launched by HACETTEPE UNIVERSITY · May 31, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
Venous Thromboembolism (VTE) refers to interrelated diagnoses such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). 10-20% of venous thromboembolic events occur in medical patients and 10-80% in intensive care patients. Recognized as a major complication for medical and surgical patients, VTE has been described as the 'silent killer' of hospitalized patients. During the Covid-19 pandemic in recent years, high rates of thrombolytic events have been reported in hospitalized COVID-19 patients. Nurses have an important role in identifying risk factors for VTE, taking precautions and a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • To be conscious,
- • Consent of the patient's relatives to participate in the study in unconscious patients
- • 24 hours have passed since hospitalization
- • The patient admitted to hospitalization has been pre-assessed by the nurse and the pre-assessment form and nurse observation form have been completed
- Exclusion Criteria:
- • Surgical patients
- • Pregnant patients
- • Refusing to participate in the study during the completion of the data collection forms.
- • In unconscious patients, the patient's relatives did not give consent to participate in the study
- • Unconscious patient whose relatives cannot be reached
- • The patient admitted to hospitalization was not pre-assessed by the nurse and the pre-assessment form and nurse observation form were not filled out
Trial Officials
Humeyra Zengin
Principal Investigator
Director of Nursing Services
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Altındağ, Ankara, Turkey
Ankara, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0